chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Nuclear magnetic resonance imaging normal, Red blood cell sedimentation rate normal, Rheumatoid factor negative, Thyroid function test normal
Clinical narrative: Information has been received from a registered nurse concerning an 18 year old female with an allergy to naproxen who on 23-APR-2008 was vaccinated with a second dose of GARDASIL. The patient was vaccinated with a third dose of GARDASIL at college so exact date was unknown. Concomitant therapy included NUVARING. After the 3rd dose of vaccination, in early November 2008 the patient developed intermittent chest pain. She had been having "sharp left-sided chest pain that radiated up the chest". It was typically moderate but sometimes severe. On occasion it had radiated to the right side and one time it went down her back. It happened with rest and activity. It happened randomly without an identified precipitating factor. Typically the pain lasted 2 minutes and happened 4 to 5 times daily. Her longest episode happened only one time and lasted 45 minutes. She had a hard time catching her breath when the pain occurred but otherwise normal breathing. She denied palpitations, crushing chest pain and no sweating. The patient sought medical attention via phone and on an unspecified date the patient went to the ER and was not admitted to the hospital. Tests were normal. She had a negative magnetic resonance imaging, chest X-ray and electrocardiogram. A complete metabolic panel, complete blood cell count, erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, antinuclear antibodies choice screen and thyroid tests were conducted in the city where the patient attended college and all the results were normal. Her internist tried a "prednisone burst" with no improvement, then tried PRILOSEC for acid reflux with no improvement. She was being followed by an internal medicine specialist who believed the problem was musculoskeletal and her mom felt it was a "muscle spasm". She was given  FLEXERIL, ibuprofen and heat. The patient refused physical therapy. She was waiting additional lab work (results unknown). The patient missed her last appointment so her current condition was unknown. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Nausea
Clinical narrative: Information has been received from a consumer concerning her 23 year old daughter with no pertinent medical history and no known drug allergies or reactions who in August 2008, was vaccinated with the first dose of GARDASIL (lot # not provided). There was no concomitant medication. In August 2008, the patient experienced nauseous constantly. No lab diagnostics studies were performed. The patient had not gotten the second dose of GARDASIL and did not plan on receiving it. At the time of reporting, the patient's nausea persisted. The patient did not seek medical attention. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection
Clinical narrative: Information has been received from a physician concerning a female who on an unspecified dates was vaccinated with first and second doses of GARDASIL (dose, route and lot number not provided). The physician reported that after receiving the two doses the patient was diagnosed with human papilloma virus (HPV). The patient sought unspecified medical attention. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Clinical narrative: Information has been received from a school nurse (registered nurse concerning a high school aged female who was vaccinated with a dose of GARDASIL. On an unspecified date, after receiving GARDASIL, the patient developed aluminum poisoning. The patient sought unspecified medical attention. Additional information was received from the school nurse and an office manager concerning the 15 year old high school female who on 31-JUL-2007 was vaccinated with the first dose of GARDASIL (lot #: 658094/0524U), on 5-OCT-2008 was vaccinated with the second dose (lot # : 658282/0929U) and on 6-FEB-2008 was vaccinated with the third dose (lot #: 659657/1487U). It was reported that the patient did not have poisoning but had a reaction to GARDASIL. This is one of several report received from the same source. Additional information has been requested.  5/1/09 Received PCP vaccine & medical records of 7/31/07-11/24/08 FINAL DX: none provided Records reveal patient experienced good health on 7/31/07 & 8/5/08.  RTC 9/26/08 & 11/14/08 w/abdominal pain & nausea.  Dx w/GERD.  RTC 11/24 w/strep pharyngitis
Age: 31.0
Sex: M
Vaccine: TTOX, TTOX
Symptoms: Blood lactic acid decreased, Blood pressure decreased, Computerised tomogram abnormal, Diarrhoea, Injection site erythema
Clinical narrative: SWELLING OF ARM AT INJECTTION SITE, DIARRHEA, VOMITING, FEVER. SYMPTOMS BEGAN 24 HOURS AFTER PATIENT RECEIVED VACCINE. ERYTHEMA EDEMA OF THE RIGHT DELTOID. DECREASED BLOOD PRESSURE
Age: 31.0
Sex: M
Vaccine: TTOX, TTOX
Symptoms: Injection site oedema, Injection site swelling, Pyrexia, Vomiting, X-ray abnormal
Clinical narrative: SWELLING OF ARM AT INJECTTION SITE, DIARRHEA, VOMITING, FEVER. SYMPTOMS BEGAN 24 HOURS AFTER PATIENT RECEIVED VACCINE. ERYTHEMA EDEMA OF THE RIGHT DELTOID. DECREASED BLOOD PRESSURE
Age: 31.0
Sex: M
Vaccine: TTOX, TTOX
Symptoms: Blood lactic acid, Blood pressure decreased, Diarrhoea, Injection site erythema, Injection site oedema
Clinical narrative: SWELLING OF ARM AT INJECTTION SITE, DIARRHEA, VOMITING, FEVER. SYMPTOMS BEGAN 24 HOURS AFTER PATIENT RECEIVED VACCINE. ERYTHEMA EDEMA OF THE RIGHT DELTOID. DECREASED BLOOD PRESSURE
Age: 31.0
Sex: M
Vaccine: TTOX, TTOX
Symptoms: Injection site swelling, Pyrexia, Vomiting, X-ray abnormal
Clinical narrative: SWELLING OF ARM AT INJECTTION SITE, DIARRHEA, VOMITING, FEVER. SYMPTOMS BEGAN 24 HOURS AFTER PATIENT RECEIVED VACCINE. ERYTHEMA EDEMA OF THE RIGHT DELTOID. DECREASED BLOOD PRESSURE
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, HEP, DTAPIPVHIB, HEP, DTAPIPVHIB, HEP
Symptoms: Autopsy, Death
Clinical narrative: Initial report received 17 April 2009 from a health care professional. A 10-week-old male patient with no previous medical history, had received an intramuscular left thigh injection of PENTACEL, lot number C3277AA and an intramuscular right thigh injection of RECOMBIVAX HB, lot 1446X (manufacturer Merck) on 14 April 2009 and one day later, the patient died while napping. The patient had been taken to his parents place of business, a nail salon, on 15 April 2009. The patient was put down for a nap at approximately 11:00 am and never woke up. Prior to death, the patient was well and had no symptoms of illness. At the time of vaccination, he had no illness, no pre-existing medical conditions and he had not been taking any concomitant medications. He had not received any other vaccines within four weeks of PENTACEL and RECOMBIVAX HB vaccination. On 16 April 2009, an autopsy had been performed, however results were pending. A cause of death was not reported. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 6.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL, DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Erythema, Local reaction, Soft tissue infection, Swelling
Clinical narrative: Redness, swelling ANT  LT Thigh, delayed onset after immunizations 4/9 am, either soft tissue infection (cellulitis) vs delayed and severe local reaction (Photo attached color copy available)
Age: 6.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL, DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Redness, swelling ANT  LT Thigh, delayed onset after immunizations 4/9 am, either soft tissue infection (cellulitis) vs delayed and severe local reaction (Photo attached color copy available)
Age: 3.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 10 X 12 cm red patch on L thigh 2 days with vaccine administration tender + hot no systemic signs or symptoms.
Age: 5.0
Sex: M
Vaccine: PNC
Symptoms: Antibody test negative, Drug ineffective, Ear infection, Nasopharyngitis, Tonsillitis
Clinical narrative: This case was considered medically important. Information regarding PREVNAR was received from a consumer regarding a 5-year-old male patient who experienced blood work showed no antibodies, ear infections, drug ineffective, colds and tonsillitis. The patient received the fourth dose on an unspecified date. The patient had blood work done on 10-Apr-2009 which showed no antibodies, Since he has turned 5 years of age, the patient has been experiencing ear infections, colds and tonsillitis. The physician is considering a fifth dose of the PREVNAR. Outcome was unknown. No additional information was available at the time of this report.
Age: 0.7
Sex: F
Vaccine: DTAPHEPBIP, HIBV
Symptoms: Biopsy skin, Injection site pruritus, Injection site rash, Pruritus, Rash
Clinical narrative: Rash appeared over mid back and buttocks 7/30/08. Progressed to localized area over left thigh, clustered, mean spots, very pruritic. Area persisted in being itchy - 11/08 went to dermatologist.  Finally, biopsed in March of 09. Traces of Aluminum Chloride
Age: 0.7
Sex: F
Vaccine: DTAPHEPBIP, HIBV
Symptoms: Rash pruritic
Clinical narrative: Rash appeared over mid back and buttocks 7/30/08. Progressed to localized area over left thigh, clustered, mean spots, very pruritic. Area persisted in being itchy - 11/08 went to dermatologist.  Finally, biopsed in March of 09. Traces of Aluminum Chloride
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site vesicles, Pain, Scab
Clinical narrative: Call from immunization clerical staff stating client had left phone message stating that she had blisters at the site of her shingles shot.  Said area was painful.  Client seen by physician today who told her he had never seen anything like this.  He told her to put ice on it and take benadryl.  Client said call was only to report for tracking purposes.  2:30 4/20/09-  Follow up call to client today.  States initially had generalized body aching that then localized to upper back, left side neck and left arm at injection site.  This happened about a week before seeing physician (4/13/09).  Since physician visit, about 5 days after blisters appeared they broke open and are now scabbed.  States there is still redness at blister site and area is sore to touch.  States she has routine appointment with Dr 4/23/09. Client aware I am filing VAERS report.
Age: 0.4
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Crying, Emotional distress, Pyrexia
Clinical narrative: Mother called Pt. crying, unable to console X90 min. Tylenol given - phone call 4/17/09. Pt doing better, cried for 2 1/2 hrs. and is fine today- had low grade fever
Age: 5.0
Sex: F
Vaccine: HEPA
Symptoms: Clumsiness, Injection site pain, Visual impairment
Clinical narrative: After receiving a HEP A injection pt walked to front desk & ran into the exit door.  She stated "every thing was purple because the shot hurt so much.  Checked by physician afterward - BP 100/70 observed for 20 min.  Mom warned to take child to ER if H/A extreme sleepiness slurred speech etc
Age: 12.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Acute erythema  and edema extending 10 cm X 4 cm around injection site. Decreasing edema and erythema daily.
Age: 4.0
Sex: M
Vaccine: DTAPHEPBIP, HIBV, MMR, VARCEL
Symptoms: Body temperature increased, Full blood count, Injection site erythema, Injection site rash, Injection site swelling
Clinical narrative: 3-12-09. Mom called re: 4 bumps to left thigh with redness. 3-13-09 mom brought child to MD with increased redness and selling. 3-14-09 ED visit, labs drawn sent home. 3-15-09- ED visit with increased temperature, N?V, sent home.
Age: 38.0
Sex: M
Vaccine: HEPAB
Symptoms: Body temperature increased, Cough, Headache, Pain
Clinical narrative: Pt. c/o H/A (intense when moves head) aching all over and a slight cough.Tem.101.Advised to see PCP if T. 102-103 and if sxs not subsided in 48 hrs -to see PCP  Hx had not felt well last week but was fine at appointment.  4-23 PC still aching all over T.100-101 Was able to eat last night.
Age: 0.7
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Apnoea, Cyanosis
Clinical narrative: Mother states that a few hours after the patient received his shots she fed him and put him down for a nap.  She states she went in to check on him and he was blue in color.  She states she blew in his face and he started breathing and they took him to the Emergency Room.  The kept him over night for observation and he did not have any more episodes while there on a apnea monitor.  He was sent home with an apnea monitor and has a follow appointment with the doctor. 4/28/09-records received-presented to ED after cyanotic and apparently not breathing. Decreased po intake, fever. Impression:Acute life-threatening event, possible seizure, possible apnea spell.
Age: 15.0
Sex: F
Vaccine: HEP, HEPA, TTOX
Symptoms: Erythema, Oedema peripheral, Tenderness
Clinical narrative: SCHOOL NURSE PHONED TO SAY RIGHT ARM RED,SWOLLEN,TENDER--REDNESS EXTENDS 3CM BELOW ELBOW---ADVISED TO SEND TO ER
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: On evening of 4/22/09, the day after vaccination, parents noted that left arm was swollen above the elbow, red and hot to the touch.  Child had not complained of any problem with arm before this time.  Mother called primary care physician on call and was instructed to place ice on arm.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Body temperature increased, Breath holding, Crying, Pallor
Clinical narrative: WCC done on 4/15/09 at which time vaccines administered according to CDC recommended schedule.  Parents report that on 4/16/09 patient developed pale lips, pale skin of face and had episode of "holding breath/not breathing" then when child caught breath cried like in pain.  Parents brought patient to ER for evaluation, patient had Temp of 99.8 rectally and an SpO2 of 100% on room air, and determined to be fine. ER doctor advised parents to follow up with babies PCP.  Patient seen in office on 4/17/09 and determined to be fine by Dr.
Age: 52.0
Sex: M
Vaccine: TDAP
Symptoms: Myalgia
Clinical narrative: Extreme muscle pain in the deltoid area beginning withing days after the shot.  It has been 9 months and the pain is only slightly better.
Age: 18.0
Sex: M
Vaccine: HEPAB, MNQ
Symptoms: Abdominal discomfort, Diarrhoea, Dizziness, Feeling abnormal, Headache
Clinical narrative: Took 1st dose of oral typhoid in the morning of 4-21-09 and began to feel intestinal discomfort the in evening of the same date.  Started with diarrhea the morning of 4-22-09 and began to experience dizziness later in the morning.  Was sitting in a university class when he started to feel horrible.  He walked out into the hall and remembers blacking out and coming to.  Went home and took a nap and when he woke up he had a severe headache.  Followed up with patient this morning 4-23-09 and said he is feeling much better today.
Age: 18.0
Sex: M
Vaccine: HEPAB, MNQ
Symptoms: Loss of consciousness
Clinical narrative: Took 1st dose of oral typhoid in the morning of 4-21-09 and began to feel intestinal discomfort the in evening of the same date.  Started with diarrhea the morning of 4-22-09 and began to experience dizziness later in the morning.  Was sitting in a university class when he started to feel horrible.  He walked out into the hall and remembers blacking out and coming to.  Went home and took a nap and when he woke up he had a severe headache.  Followed up with patient this morning 4-23-09 and said he is feeling much better today.
Age: 4.0
Sex: F
Vaccine: FLU3, MMR
Symptoms: Injection site discolouration
Clinical narrative: After administration of a subcutaneous MMR vaccination using a VanishPoint syringe, a black dot appeared on the site of injection.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Abdominal pain, Diarrhoea, Dizziness postural, Fatigue, Nausea
Clinical narrative: Diarrhea nausea w/o emesis and Crampy abdominal pain 30+ episdoes of watery diarrhea no blood in 24 hours. Orthostatic and fatigue.
Age: 4.0
Sex: F
Vaccine: HEPA, MMR
Symptoms: Injection site discolouration
Clinical narrative: After a subcutaneous injection of the MMR vaccine using the VanishPoint syringe, a black dot appeared on the child's left arm.
Sex: F
Vaccine: DTAP
Symptoms: Chills, Hypoaesthesia, Pyrexia
Clinical narrative: RECEIVED T-DAP 4/1/09 AT BEGINNING OF 12 HOUR SHIFT (0700) AND HER SHIFT EXTENEDED UNTIL 0300 THE NEXT DAY.  ON THE NIGHT OF 4/3/09 SHE HAD A FEVER, CHILLS, AND NUMBNESS IN HER HANDS AND FEET.  FEVER RESOLVED WITH IBUPROFEN.  SYMPTOMS RESOLVED BY MORNING OF 4/4/09.
Age: 61.0
Sex: F
Vaccine: PPV, TDAP, VARZOS
Symptoms: Dizziness, Injection site pain, Injection site reaction, Lymphadenopathy, Nausea
Clinical narrative: developed severe pain at injection site and upper arm,prickly reddened area around site, dizziness, fever,, nausea,lymph glands swollen in axilla
Age: 61.0
Sex: F
Vaccine: PPV, TDAP, VARZOS
Symptoms: Paraesthesia, Pyrexia
Clinical narrative: developed severe pain at injection site and upper arm,prickly reddened area around site, dizziness, fever,, nausea,lymph glands swollen in axilla
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Feeling hot, Hypotonia, Unresponsive to stimuli
Clinical narrative: Within 2-3 minutes after second vaccine injection(HPV) client stated that she felt hot,then did not respond to verbal stimuli, eyes open, and body began to become limp and slumped forward while sitting in chair. Client was assisted by two staff to the floor. Client placed on her back and legs were elevated. Client responsive and apple juice and granola bar given. Client tolerated juice and granola without difficulty and held appropriate conversation with staff. B/P 110/70 P-80 Resp-16. Client with this staff for 20 mins after incident and ambulated without difficulty and had no complaints upon leaving the clinic.
Age: 38.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Activities of daily living impaired, Diarrhoea, Erythema, Injection site erythema, Injection site pain
Clinical narrative: On 4/21/2009, arm was sore and red at site of injection. Redness gradually worsened. At time indicated in number 11, patient began to feel nauseated. Later that day, arm very red and hot, fever developed (102.0 F) and felt achey all over. Antibiotics prescribed by physician for presumed cellulitis, began taking these at 5:30 PM on 4/22. At ~3:00 AM on 4/23, patient vomited. Loose stools and nausea have been experienced since that time, but no further vomiting. Patient has missed 1.5 days from work and probably will miss 4/24 also. Physician has indicated that IV antibiotics may be necessary.
Age: 38.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Nausea, Pain, Pyrexia, Skin warm, Vomiting
Clinical narrative: On 4/21/2009, arm was sore and red at site of injection. Redness gradually worsened. At time indicated in number 11, patient began to feel nauseated. Later that day, arm very red and hot, fever developed (102.0 F) and felt achey all over. Antibiotics prescribed by physician for presumed cellulitis, began taking these at 5:30 PM on 4/22. At ~3:00 AM on 4/23, patient vomited. Loose stools and nausea have been experienced since that time, but no further vomiting. Patient has missed 1.5 days from work and probably will miss 4/24 also. Physician has indicated that IV antibiotics may be necessary.
Age: 38.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Erythema, Oedema peripheral, Pyrexia, Skin warm, Tenderness
Clinical narrative: On 4/21/2009, arm was sore and red at site of injection. Redness gradually worsened. At time indicated in number 11, patient began to feel nauseated. Later that day, arm very red and hot, fever developed (102.0 F) and felt achey all over. Antibiotics prescribed by physician for presumed cellulitis, began taking these at 5:30 PM on 4/22. At ~3:00 AM on 4/23, patient vomited. Loose stools and nausea have been experienced since that time, but no further vomiting. Patient has missed 1.5 days from work and probably will miss 4/24 also. Physician has indicated that IV antibiotics may be necessary.
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Mass, Pain in extremity, Pyrexia
Clinical narrative: L upper arm redness, swelling, fever, skin hot, red rash on arm, pain in arm for one week, egg sized lump. Symptoms resolved on own after one week. Pt reported after symptoms gone.
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Rash erythematous, Skin warm
Clinical narrative: L upper arm redness, swelling, fever, skin hot, red rash on arm, pain in arm for one week, egg sized lump. Symptoms resolved on own after one week. Pt reported after symptoms gone.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Site where shingles vaccine administered on the 21st of April at 10:00a.m., became very red, itchy and swollen to three inches in diameter, 1/2 inch high, rash covered the whole area, and arm was hurting so bad, patient took 2 ibuprophen every 4 hours along with 1 tsp.demerol (for likely alergy). Site is still red and itchy, but not as painful after 3rd day, but 50% better. Cold compresses help.  My husband had same vaccine at same time, and his arm was hurting, but did not have the rash.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: After leaving office Pt had a delayed fainting spell - Returned to office - No injury.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Injected limb mobility decreased, Injection site pain, Malaise, Nausea
Clinical narrative: 4 hours after injection - pain at site -nausea-vomiting 9 hrs- Temp -101.4 - 12 hrs. See attached for detailed acct
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Paraesthesia, Retching, Vomiting
Clinical narrative: 4 hours after injection - pain at site -nausea-vomiting 9 hrs- Temp -101.4 - 12 hrs. See attached for detailed acct
Age: 8.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Anorexia, Body temperature increased, Cough, Fatigue, Streptococcal identification test positive
Clinical narrative: Temperature starting within 24 hours of injections with lack of appetite & fatigue.  Cough developed within 24 hours with positive strep (rapid test) 3/31/09.  Pt given script for AMOXICILLIN.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Left arm is red, swollen, itchy
Age: 1.3
Sex: F
Vaccine: DTAPIPVHIB, PNC
Symptoms: Injection site erythema, Injection site warmth, Pyrexia
Clinical narrative: Fever 101 degrees (rectal) on 4/23/09, redness and warmth to both thighs
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site urticaria, Injection site warmth
Clinical narrative: Pt noticed red area on LA last night 4/15/09. School nurse (called 4/16/09). 3/4" wheel - 2" flare -red-hot; dermis itching - no rash- no resp. problems (Lower (L) deltoid are at injection site) - cold compress applied- Sch - nurse will observe 4/23 child is fine; spoke with mom 4/15/09. Nurse to mom 4/20 and 4/21 for flu - TAN - no response
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MEA, VARCEL
Symptoms: Body temperature increased, Feeling hot, Vomiting
Clinical narrative: 5-10 min after vaccines given mom stated pt vomited in bathroom.  Once out of bathroom mom stated pt feet "hot".  Temp was 99.8 axillary 15 min later temp was 101.6 - Gave 5mL children's ibuprofen checked temp - 100.0 axillary.
Age: 54.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Injection site oedema, Pain, Skin warm
Clinical narrative: Pt reported redness, swelling, pain 5/10 and heat stating 4 days after injection. Erythematous and edematous area 9 cm X 7.5 cm at injection site. Started on ABx BACTRIM. Improved within 24 hours.
Age: 54.0
Sex: F
Vaccine: PPV
Symptoms: Swelling
Clinical narrative: Pt reported redness, swelling, pain 5/10 and heat stating 4 days after injection. Erythematous and edematous area 9 cm X 7.5 cm at injection site. Started on ABx BACTRIM. Improved within 24 hours.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site urticaria
Clinical narrative: On 4/17/09, he was given MMR in right upper arm. Later that evening, he developed a red whelp and swelling of the right upper arm (deltoid area) No dyspnoea, No dyphasia, No systemic rxn.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 10cm X 8cm redness & swelling around site of immunization left and lateral thigh
Age: 1.36
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Induration, Pyrexia, Rash erythematous, Rash generalised, Rash papular
Clinical narrative: Mild rash appeared on arm in vicinity of vaccines - 4 days later on 04/6/09 and 4/20 severe rash on face - 4/21 severe generalized indurated pink papular rash all over, fever - 4/23 improving.
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, IPV, VARCEL
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: 4 y. o received varicella vaccine on 4/21/09.  Developed edema of R arm extending from deltoid to mid forearm erythema over deltoid.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR
Symptoms: Erythema, Feeling hot, Inflammation
Clinical narrative: Red, warm to touch, inflammation instructed to give child, children's Motrin or Advil.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Pt L upper arm is red, hot to the touch and feels hard @ injection site.  <- hist Dx  Skin is mildly red-not hard child not ill- playful- afebrile.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Raised irregular shaped welts - No temp. - Itchy on parts of arm/legs and torso - Recommended BENADRYL _ See Dr. if not better.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, PNC, RV1
Symptoms: Full blood count, Irritability, Pyrexia
Clinical narrative: fever fussiness symptomatic tx
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Soreness, swelling, heat  (L) upper arm and developed several hrs after injection, Rx BENADRYL/VICODIN and cold packs.
Age: 45.0
Sex: F
Vaccine: TDAP
Symptoms: Burning sensation, Fatigue, Pain, Pruritus, Swelling
Clinical narrative: Swelling, itching - burning - tired - achy Had emp. health physician check patient
Age: 18.0
Sex: F
Vaccine: TDAP
Symptoms: Eye irritation, Eye pruritus, Oropharyngeal blistering, Swollen tongue
Clinical narrative: Half hour post pt left boyfriend called back stating pt's tongue was starting to swell & have blisters on tongue.  Told boyfriend to return to clinic.  Dr examined pt & ordered 50 mg of BENADRYL IM.  Let pt set for half hour & then rechecked pt.  Tongue s/s were getting better but now was c/o left eye itching & pt & felt it was BENADRYL kicking in.  BP at recheck was 104/82 (5:50 pm).  When pt left at 1800 pt BP 108/76 was c/o eyes (bil) burning but felt ok.  Symptoms resolved.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Cough, Dyspnoea, Pallor, Rash generalised, Rash pruritic
Clinical narrative: Within 20 min child had cough, wheezing, difficulty breathing, pale Oxy 93-96% on room air then developed itchy rash all over the body. Got XOPENEX nebulization, prednisolone PO -ZYRTEC PO and Epinephrine. Patient referred to nearest Pediatric Emergency Room by EMS
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Wheezing
Clinical narrative: Within 20 min child had cough, wheezing, difficulty breathing, pale Oxy 93-96% on room air then developed itchy rash all over the body. Got XOPENEX nebulization, prednisolone PO -ZYRTEC PO and Epinephrine. Patient referred to nearest Pediatric Emergency Room by EMS
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Red hard spot at injection site.
Age: 1.0
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Rash
Clinical narrative: presented 4/22/09 with rash.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, RV1
Symptoms: Pyrexia, Rash erythematous, Rash macular
Clinical narrative: Tactile. Fever and erythematous, blotchy rush all over - day after PENTACEL  and ROTARIX
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old male patient who experienced injection site reaction characterized by injection site erythema and injection site induration size of 1 inch x 1.5 inches. The patient received the fourth dose on 14-Jan-2008. The patient also received a dose of Tuberculin (manufacturer unknown) and a dose of Hep A (manufacturer unknown) on 14-Jan-2008. The patient experienced injection site reaction characterized by injection site erythema and injection site induration size of 1 inch x 1.5 inches in 2008. The patient recovered in 2 to 3 days. No additional information was available at the time of this report.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old male patient who experienced injection site reaction characterized by injection site erythema and injection site induration size of 1 inch x 1.5 inches. The patient received the fourth dose on 03-Jan-2008. The patient also received a dose of Tuberculin Ppd (manufacturer unknown) and a dose of Hepatitis A Vaccine (manufacturer unknown) on 03-Jan-2008. The patient experienced injection site reaction characterized by injection site erythema and injection site induration size of 1 inch x 1.5 inches in 2008. The patient recovered in 2 to 3 days. No additional information was available at the time of this report.
Age: 1.0
Sex: F
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old female patient who experienced injection site reaction characterized by injection site erythema and injection site induration size of 1 inch x 1.5 inches. The patient received a dose on 08-Jan-2008. The patient also received a dose of Ppd Disposable (Bcg Seizo Co. Ltd.) and a dose of Hepatitis A Vaccine (manufacturer unknown) on 08-Jan-2008. The patient experienced an injection site reaction characterized by injection site erythema and injection site induration size of 1 inch x 1.5 inches in 2008. The patient recovered in 2 to 3 days. No additional information was available at the time of this report.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old male patient who experienced injection site reaction characterized by injection site erythema and injection site induration size 30 mm x 40 mm. The patient received the fourth dose on 08-Mar-2008. The patient also received a dose of Hepatitis A Vaccine (manufacturer unknown) on 08-Mar-2008. The patient experienced injection site reaction characterized by injection site erythema and injection site induration size 30 mm x 40 mm. The event resolved within two to three days. No additional information was available at the time of this report.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old male patient who experienced injection site reaction characterized by injection site erythema and injection site induration size 30 mm x 30 mm. The patient received the fourth dose on 17-Mar-2008. The patient experienced injection site reaction characterized by injection site erythema and injection site induration size 30 mm x 30 mm in Mar-2008. The reporter noted it took 2 to 3 days for the reaction to resolve. No additional information was available at the time of this report.
Age: 0.2
Sex: M
Vaccine: HIBV, PNC
Symptoms: Erythema, Irritability
Clinical narrative: Follow-up information was received that provided information that no laboratory tests were conducted, no concomitant medications were given, and the patient had no illness at the time of vaccination. Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old male patient who received the first dose on 23-May-2008 along with the first dose of ACT-HIB (Aventis) and experienced irritability and local erythema. On 23-May-2008, the patient experienced irritability and local erythema. The patient recovered. No additional information was available at the time of this report.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old male patient who experienced injection site reaction characterized by mild injection site erythema and injection site induration. The patient received the fourth dose on 17-Jan-2008. The patient also received a dose of Tuberculin PPD (manufacturer unknown) and a dose of Hepatitis A Vaccine (manufacturer unknown) on 17-Jan-2008. The patient experienced injection site reaction characterized mild injection site erythema and injection site induration in 2008. The patient recovered in 2 to 3 days. No additional information was available at the time of this report.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5, DTAPHEPBIP, PNC, RV5
Symptoms: Crying, Immediate post-injection reaction
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old male patient who experienced inconsolable crying. At 2 months of age, the patient received the first dose on 16-Jul-2008. The patient also received the first dose of PEDIARIX (GlaxoSmithKline) and ROTATEQ on 16-Jul-2008. The patient experienced inconsolable crying on 16-Jul-2008 immediately after being administered the PEDIARIX vaccine. The patient was taken to the Emergency Room but was not admitted to the hospital. The crying lasted until 22:00 on 16-Jul-2008. The reporting nurse considered the crying related to the vaccination with PEDIARIX. The patient recovered. No additional information was available at the time of this report.
Age: 0.21
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Blood culture positive, CSF culture positive, Chest X-ray normal, Drug ineffective, Gram stain
Clinical narrative: Follow-up provided medical history, event details, and outcome. Follow-up provided Quality Assurance Results. Information regarding PREVNAR was received from a healthcare professional regarding a 3-month-old patient who experienced drug ineffective and pneumococcal meningitis. At 2 months of age, the patient received the first dose on 28-Aug-2008. The patient also received the first dose of PENTACEL (Aventis-Pasteur), the second dose of H-B-VAX (Merck Sharp & Dome) and the first dose of ROTATEQ (Merck) on 28-Aug-2008. The patient experienced pneumococcal meningitis on 13-Sep-2008. The patient was hospitalized and in the Intensive Care Unit. The patient recovered. No additional information was available at the time of this report. The events were also considered life threatening. No additional information was available at the time of this report.
Age: 0.21
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Gram stain negative, Gram stain positive, Intensive care, Meningitis pneumococcal, Streptococcal identification test positive
Clinical narrative: Follow-up provided medical history, event details, and outcome. Follow-up provided Quality Assurance Results. Information regarding PREVNAR was received from a healthcare professional regarding a 3-month-old patient who experienced drug ineffective and pneumococcal meningitis. At 2 months of age, the patient received the first dose on 28-Aug-2008. The patient also received the first dose of PENTACEL (Aventis-Pasteur), the second dose of H-B-VAX (Merck Sharp & Dome) and the first dose of ROTATEQ (Merck) on 28-Aug-2008. The patient experienced pneumococcal meningitis on 13-Sep-2008. The patient was hospitalized and in the Intensive Care Unit. The patient recovered. No additional information was available at the time of this report. The events were also considered life threatening. No additional information was available at the time of this report.
Age: 0.7
Sex: F
Vaccine: HIBV, PNC
Symptoms: Blood glucose normal, Body temperature increased, Cardiovascular evaluation, Dyskinesia, Febrile convulsion
Clinical narrative: This case was considered medically important. Follow-up information provided patient demographics, test results, product details, suspect and concomitant vaccines and event details. Information regarding PREVNAR was received from a healthcare professional regarding an 8-month-old female patient who experienced febrile seizure. At 8 months of age, the patient received the first dose of PREVNAR and the first dose of ACT-HIB (Aventis) on 02-Oct-2008. Suspect medication included ACT-HIB (Aventis). Several hours after being administered the PREVNAR and ACT-HIB vaccines, the infant had jerking and rhythmic movements lasting approximately 2 seconds in duration. Immediately thereafter, she was appropriate and interactive. Around 10 pm that evening, she woke up and was given TYLENOL. Sometime thereafter, the infant had another episode of the jerking and rhythmic movements. The infant had 6 of these episodes that were witnessed by her mother. She was taken to the Emergency Room. Examination revealed that the infant was alert, playful and acting appropriately (see test results below). Rectal temperature was 38.7 degrees C. Treatment included MOTRIN. Finger stick glucose was normal. The infant was given a bottle of PEDIALYTE which she tolerated. A febrile seizure was diagnosed. She was discharged home and was to follow-up with her primary care physician as soon as possible. The patient was considered recovered. No additional information was available at the time of this report.
Age: 0.7
Sex: F
Vaccine: HIBV, PNC
Symptoms: Gastrointestinal examination normal, Heart rate, Neurological examination normal, Orthopedic examination normal, Respiratory rate
Clinical narrative: This case was considered medically important. Follow-up information provided patient demographics, test results, product details, suspect and concomitant vaccines and event details. Information regarding PREVNAR was received from a healthcare professional regarding an 8-month-old female patient who experienced febrile seizure. At 8 months of age, the patient received the first dose of PREVNAR and the first dose of ACT-HIB (Aventis) on 02-Oct-2008. Suspect medication included ACT-HIB (Aventis). Several hours after being administered the PREVNAR and ACT-HIB vaccines, the infant had jerking and rhythmic movements lasting approximately 2 seconds in duration. Immediately thereafter, she was appropriate and interactive. Around 10 pm that evening, she woke up and was given TYLENOL. Sometime thereafter, the infant had another episode of the jerking and rhythmic movements. The infant had 6 of these episodes that were witnessed by her mother. She was taken to the Emergency Room. Examination revealed that the infant was alert, playful and acting appropriately (see test results below). Rectal temperature was 38.7 degrees C. Treatment included MOTRIN. Finger stick glucose was normal. The infant was given a bottle of PEDIALYTE which she tolerated. A febrile seizure was diagnosed. She was discharged home and was to follow-up with her primary care physician as soon as possible. The patient was considered recovered. No additional information was available at the time of this report.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Dyspnoea, Movement disorder
Clinical narrative: Follow-up information pertaining to patient demographics, medical history and lab tests was received. Information regarding PREVNAR was received from a healthcare professional regarding a 6-month-old female patient who experienced seizures. At 6 months of age, the patient received the third dose on 18-Dec-2008. The patient also received the third dose of INFANRIX PENTA and the third dose of Hib (manufacturer unknown) on 18-Dec-2008. The patient experienced seizures on 22-Dec-2008 and was hospitalized. The outcome was reported as unknown. The reporter commented that the patient is being worked up for reflux and apnea secondary to obstruction. No additional information was available at the time of this report.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Convulsion, Electroencephalogram, Obstruction
Clinical narrative: Follow-up information pertaining to patient demographics, medical history and lab tests was received. Information regarding PREVNAR was received from a healthcare professional regarding a 6-month-old female patient who experienced seizures. At 6 months of age, the patient received the third dose on 18-Dec-2008. The patient also received the third dose of INFANRIX PENTA and the third dose of Hib (manufacturer unknown) on 18-Dec-2008. The patient experienced seizures on 22-Dec-2008 and was hospitalized. The outcome was reported as unknown. The reporter commented that the patient is being worked up for reflux and apnea secondary to obstruction. No additional information was available at the time of this report.
Age: 0.2
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, DTAPHEPBIP, HIBV, PNC
Symptoms: Rash
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old female patient who experienced rash at the injection site. The patient received the first dose on 26-Jan-2009. The patient experienced rash at the injection site on 26-Jan-2009. Outcome was reported as not recovered. No additional information was available at the time of this report.
Age: 0.2
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, DTAPHEPBIP, HIBV, PNC
Symptoms: Injection site rash
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old female patient who experienced rash at the injection site. The patient received the first dose on 26-Jan-2009. The patient experienced rash at the injection site on 26-Jan-2009. Outcome was reported as not recovered. No additional information was available at the time of this report.
Age: 0.57
Sex: F
Vaccine: RV5, DTAPHEPBIP, FLU3, HIBV, PNC, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Diarrhoea, Oliguria, Pyrexia, Vomiting
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 6-month-old female patient who experienced diarrhea, vomiting, fever of 101.6 degrees F. and voiding once every 24 hours. At 6 months of age, the patient received the third dose on 06-Jan-2009. The patient also received the second dose of HIBEST (Pasteur Vaccins) and the third dose of PEDIARIX (Glaxosmithkline) on 06-Jan-2009. Additional suspect medication included ROTARIX. The patient experienced diarrhea, vomiting and fever of 101.6 degrees F. and voiding once every 24 hours on 06-Jan-2009. Outcome was reported as not recovered. No additional information was available at the time of this report.
Age: 0.57
Sex: F
Vaccine: RV5, DTAPHEPBIP, FLU3, HIBV, PNC, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Diarrhoea, No reaction on previous exposure to drug, Pyrexia, Urine output decreased, Vomiting
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 6-month-old female patient who experienced diarrhea, vomiting, fever of 101.6 degrees F. and voiding once every 24 hours. At 6 months of age, the patient received the third dose on 06-Jan-2009. The patient also received the second dose of HIBEST (Pasteur Vaccins) and the third dose of PEDIARIX (Glaxosmithkline) on 06-Jan-2009. Additional suspect medication included ROTARIX. The patient experienced diarrhea, vomiting and fever of 101.6 degrees F. and voiding once every 24 hours on 06-Jan-2009. Outcome was reported as not recovered. No additional information was available at the time of this report.
Age: 0.57
Sex: F
Vaccine: RV5, DTAPHEPBIP, FLU3, HIBV, PNC, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Diarrhoea, Pyrexia, Urine output decreased, Vomiting
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 6-month-old female patient who experienced diarrhea, vomiting, fever of 101.6 degrees F. and voiding once every 24 hours. At 6 months of age, the patient received the third dose on 06-Jan-2009. The patient also received the second dose of HIBEST (Pasteur Vaccins) and the third dose of PEDIARIX (Glaxosmithkline) on 06-Jan-2009. Additional suspect medication included ROTARIX. The patient experienced diarrhea, vomiting and fever of 101.6 degrees F. and voiding once every 24 hours on 06-Jan-2009. Outcome was reported as not recovered. No additional information was available at the time of this report.
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5, DTAPIPVHIB, PNC, RV5
Symptoms: Muscle twitching, Pyrexia, Urine analysis normal, Urine odour abnormal, Vomiting
Clinical narrative: Additional information provided pediatric milestones, and updated source demographics. Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old male patient who experienced fever, twitching and vomiting. The patient received a dose on 11-Dec-2008. Additional suspect medication included ROTATEQ and PENTACEL. On 11-Dec-2008, post-vaccination, the patient experienced fever with a temperature of 100.3 Fahrenheit, twitching and vomiting. The mother returned to the office the following day. The outcome of the events was unknown. No additional information was available at the time of this report.
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5, DTAPIPVHIB, PNC, RV5
Symptoms: Body temperature increased, Muscle twitching, Pyrexia, Vomiting
Clinical narrative: Additional information provided pediatric milestones, and updated source demographics. Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old male patient who experienced fever, twitching and vomiting. The patient received a dose on 11-Dec-2008. Additional suspect medication included ROTATEQ and PENTACEL. On 11-Dec-2008, post-vaccination, the patient experienced fever with a temperature of 100.3 Fahrenheit, twitching and vomiting. The mother returned to the office the following day. The outcome of the events was unknown. No additional information was available at the time of this report.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, PNC
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old female patient who experienced injection site induration (5-6 in diameter). The patient received the fourth dose on 23-Feb-2009. The patient experienced injection site redness (5-6 in diameter) and injection site induration (5-6 in diameter) on 23-Feb-2009. The patient had not recovered from injection site redness. The outcome of the injection site induration was unknown. No additional information was available at the time of this report.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old female patient who experienced injection site induration (5-6 in diameter). The patient received the fourth dose on 23-Feb-2009. The patient experienced injection site redness (5-6 in diameter) and injection site induration (5-6 in diameter) on 23-Feb-2009. The patient had not recovered from injection site redness. The outcome of the injection site induration was unknown. No additional information was available at the time of this report.